[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work with us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Flexible Training
    • Good Distribution Practice (GDP) Training
    • RPi Training
    • Licence Holder Training
    • Export Training
    • Audit Training
    • Active Pharmaceutical Ingredient (API) and Clinical Trials Training
    • Superintendent Pharmacist Training
    • GPhC Guidance for Online Pharmacies
  • RP Cogent GDP Training
  • RP Forum
  • Training Calendar
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
Journalists – Be Careful What You Write About Medicines

Journalists – Be Careful What You Write About Medicines

by Steven Hewison | Apr 30, 2025 | Blog, MHRA

The MHRA continue to scrutinise and take action against Pharmacies and Clinics who are promoting Prescription Only Medicines (POMs) to the public. However, this month’s advertising investigations bulletin also includes action against a journalist newspaper article.

Emerging Risks in Pharmacy Practice: Key Updates from the GPhC

Emerging Risks in Pharmacy Practice: Key Updates from the GPhC

by Steven Hewison | Apr 15, 2025 | Blog, GPhC, Pharmacist, Pharmacy

In this blog I want to highlight some critical updates from the General Pharmaceutical Council (GPhC) that every pharmacy professional—whether you’re a pharmacist, technician, or pharmacy owner—should be aware of. These issues have prompted serious regulatory concerns and demand thoughtful consideration and action where appropriate.

Risk Assessments for Registered Pharmacies Providing Pharmacy Services at a Distance

Risk Assessments for Registered Pharmacies Providing Pharmacy Services at a Distance

by Steven Hewison | Apr 9, 2025 | Blog, Pharmacy

Risk Assessments are a regulatory requirement in medicines wholesaling but have you considered that they could also be very useful in pharmacy practice?

New Best practice guidance on the sale of medicines for pain relief

New Best practice guidance on the sale of medicines for pain relief

by Steven Hewison | Apr 2, 2025 | Blog, MHRA, Pharmacy Suppliers

The MHRA have updated their Blue Guide on Advertising and Promoting Medicines. The update is to Appendix 4 with new Best Practice guidance on the sale of medicines for pain relief.

The Windsor Framework Part 3

The Windsor Framework Part 3

by Steven Hewison | Aug 29, 2024 | Blog, MHRA, Windsor Framework

Unless they appear on the NIMAR list, PLGB licensed medicines are not licensed in Northern Ireland. That means they are effectively supplied to NI as an Unlicensed ‘Special’.

« Older Entries

Recent Posts

  • GDP certificates do not expire
  • Parallel Trade – A reminder
  • Journalists – Be Careful What You Write About Medicines

Upcoming Courses

  • Licence Holder Training on 10 June 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 17 June 2025
  • RP Forum – Inspection Preparation and RP Readiness on 8 July 2025 10:00 am
  • GDP Audit Online Training on 9 July 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 15 July 2025

MHRA Alerts & Recalls

Philips Respironics BiPAP A series ventilators: alarm malfunction and risk of therapy interruptions in ventilators not intended for life-support, DSI/2024/006
23 May 2025
Class 2 Medicines Recall: Mercaptopurine 50mg Tablets, Aspen Pharma Trading Limited, EL (25)A/23
22 May 2025
Field Safety Notices: 12 to 16 May 2025
20 May 2025
Class 2 Medicines Recall: BD ChloraPrep Clear - 1mL Applicator, Becton Dickinson UK Ltd, EL(25)A/22
19 May 2025

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow